Last reviewed · How we verify

NCT05960123

Evaluation of TIP Urethroplasty With Spongioplasty-Dartosoraphy Reinforcement in Pediatric Hypospadias

Completed NA Last updated 25 July 2023
What this trial tests

NA trial testing Tubularized Incised Plate (TIP) urethroplasty in Hypospadias in 220 participants. Completed in 30 May 2023.

Timeline
1 April 2019
Primary endpoint
1 January 2023
30 May 2023

Quick facts

Lead sponsorAl-Azhar University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment220
Start date1 April 2019
Primary completion1 January 2023
Estimated completion30 May 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 6 Months to 14, male only, with Hypospadias or Complication,Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aimed to evaluation of Tubularized incised palate urethroplasty with spongioplasty-dartosoraphy reinforcement (group A) through comparing of functional and cosmetic results of this technique with the conventional TIP urethroplasty (group B).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypospadias

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05960123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing